The Straits Times / The Business Times News on AsiaPharm

Key AsiaPharm drug gets tick of approval

Sep 22, 2004
The Straits Times

Mainboard-listed AsiaPharm Group, a China-based drugs company, said yesterday that one of its key products has been listed as an approved drug under China's National Health Insurance List, which means the product will gain wider use in hospitals and boost the group's revenue.

The drug, which is mainly used to treat gastroenterological ailments such as gastric and duodenum ulcers, contributed 11.6 per cent to group revenue for the first half of the 2004 financial year.

AsiaPharm said it also obtained a manufacturing licence recently for a new
drug for the treatment of heart diseases. The drug will be available in the market by the end of the year.